Vikas Lifecare

Why is Vikas Lifecare Ltd falling/rising?

As of 10-Jun, Vikas Lifecare Ltd's stock price is 1.47, down 0.68%, and has significantly underperformed against the Sensex with declines over various periods. The stock is trading below key moving averages and despite increased investor participation, it reflects a bearish trend influenced by sector declines.

As of 10-Jun, Vikas Lifecare Ltd's stock price is currently at 1.47, reflecting a decrease of 0.01 or 0.68%. The stock has been underperforming compared to the benchmark Sensex, with a 1-week decline of 1.34% versus the Sensex's 0.49% drop, and a more significant 1-month decline of 8.13% compared to the Sensex's 4.33% decline. Year-to-date, the stock has fallen by 16.95%, which is worse than the Sensex's 13.19% decline. Over the past year, Vikas Lifecare has seen a substantial drop of 43.89%, while the Sensex has only decreased by 10.21%.<BR><BR>Despite today's performance showing that the stock outperformed its sector by 2.07%, it is trading below all key moving averages (5-day, 20-day, 50-day, 100-day, and 200-day), indicating a bearish trend. Additionally, the petrochemical sector, in which Vikas Lifecare operates, has experienced a decline of 2.9%. However, there has been a notable increase in investor participation, with delivery volume rising by 65.46% compared to the 5-day average, suggesting some interest in the stock despite its overall downward trajectory.<BR><BR>In summary, the combination of poor performance relative to benchmarks, trading below moving averages, and sector declines contribute to the falling stock price of Vikas Lifecare Ltd.

What does Vikas Lifecare do?

Vikas Lifecare Ltd specializes in recycling plastic waste and manufacturing polymer compounds, operating as a Micro Cap company. As of December 2025, it reported net sales of 97 Cr and a net loss of 29 Cr.

Overview: <BR>Vikas Lifecare Ltd operates in the recycling of plastic waste and the trading and manufacturing of polymer compounds, positioned within the Trading & Distributors industry and categorized as a Micro Cap company.<BR><BR>History: <BR>Vikas Lifecare Limited was originally incorporated as Vikas Multicorp Limited in 1995. The company underwent a name change to Vikas Lifecare Limited, which was formalized with a Special Resolution and a fresh Certificate of Incorporation issued on April 09, 2021. The latest quarterly results reported net sales and profit for December 2025.<BR><BR>Financial Snapshot: <BR>Net Sales: 97 Cr (Quarterly Results - Dec 2025) <BR>Net Profit: -29 Cr (Quarterly Results - Dec 2025) <BR>Market Cap: INR 279 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: N/A <BR>Industry P/E: 14 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.16 <BR>Return on Equity: -0.66% <BR>Price to Book: 0.50<BR><BR>Contact Details: <BR>Address: G 1 34/1 East Punjabi Bagh, Vikas Apartments, New Delhi, Delhi: 110026 <BR>Tel: 91-011-40450110 <BR>Email: info@vikasmulticorp.com <BR>Website: http://www.vikaslifecarelimited.com

Which are the latest news on Vikas Lifecare?

How big is Vikas Lifecare?

As of 10th June, Vikas Lifecare Ltd has a market capitalization of 279.00 Cr and reported Net Sales of 465.94 Cr, with a Net Profit loss of 26.06 Cr over the latest 4 quarters. Shareholder's Funds were 531.76 Cr and Total Assets were 724.76 Cr as of March 2025.

As of 10th June, Vikas Lifecare Ltd has a market capitalization of 279.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest 4 quarters, Vikas Lifecare reported Net Sales of 465.94 Cr. However, the company experienced a loss of 26.06 Cr in Net Profit during the same period.<BR><BR>The latest annual period for the balance sheet is March 2025, where Shareholder's Funds amounted to 531.76 Cr and Total Assets were reported at 724.76 Cr.

Should I buy, sell or hold Vikas Lifecare Ltd?

When is the next results date for Vikas Lifecare Ltd?

The next results date for Vikas Lifecare Ltd is February 7, 2026.

The next results date for Vikas Lifecare Ltd is scheduled for February 7, 2026.

How has been the historical performance of Vikas Lifecare?

Vikas Lifecare has experienced fluctuating financial performance, with net sales increasing to 480.02 Cr in March 2025, but profitability declining significantly, resulting in a net loss of -10.61 Cr. Despite growth in total assets, cash flow from operations has worsened, indicating ongoing financial challenges.

Answer:<BR>The historical performance of Vikas Lifecare shows significant fluctuations in key financial metrics over the years.<BR><BR>Breakdown:<BR>Vikas Lifecare's net sales have generally increased, reaching 480.02 Cr in March 2025 from 445.75 Cr in March 2024, although it slightly decreased from 476.05 Cr in March 2023. The total operating income followed a similar trend, peaking at 480.02 Cr in March 2025. However, the total expenditure has also risen, amounting to 501.62 Cr in March 2025, which has led to an operating profit (PBDIT) of 4.36 Cr, a decline from 30.49 Cr in the previous year. The company reported a profit before tax of -6.95 Cr in March 2025, down from 17.58 Cr in March 2024, resulting in a profit after tax of -5.00 Cr. The consolidated net profit also fell to -10.61 Cr in March 2025 from 14.03 Cr in March 2024. The total assets of Vikas Lifecare increased to 724.76 Cr in March 2025, up from 554.70 Cr in March 2024, while total liabilities rose to 724.76 Cr from 554.70 Cr in the same period. Cash flow from operating activities showed a negative trend, with -222.00 Cr in March 2025 compared to -41.00 Cr in March 2024, indicating challenges in cash generation. Overall, while Vikas Lifecare has seen growth in sales and assets, profitability has been inconsistent, reflecting a complex financial landscape.

Are Vikas Lifecare latest results good or bad?

Vikas Lifecare's latest results are disappointing, with a 23% decline in net sales to Rs 92.38 crore and a loss of Rs 3.96 crore in Profit After Tax, leading to a 'Strong Sell' rating by MarketsMOJO due to ongoing financial difficulties.

Vikas Lifecare's latest results are quite disappointing. For the quarter ending June 2025, the company reported net sales of Rs 92.38 crore, which is a significant decline of 23.0% compared to the average net sales of Rs 120.01 crore over the previous four quarters. This indicates a challenging sales environment.<BR><BR>Additionally, the company faced a loss of Rs 3.96 crore in Profit After Tax (PAT), which is a 56.2% decline from the average loss of Rs -2.54 crore in the prior four quarters. This trend suggests ongoing financial difficulties.<BR><BR>Moreover, interest expenses have increased by 36.03% over the preceding nine months, reaching Rs 4.04 crore, indicating higher borrowings that further complicate the financial situation. Overall, these results have led to a 'Strong Sell' rating by MarketsMOJO, reflecting a negative outlook for the company.

Who are the peers of the Vikas Lifecare?

Vikas Lifecare's peers include Oswal Agro Mills, Veritas (India), and Mehai Technology, among others. Oswal Agro Mills and Mehai Technology show excellent management and growth, while Vikas Lifecare has a 1-year return of -50.39%, better than Veritas (India) but worse than Mehai Technology's 398.50%.

Peers: The peers of Vikas Lifecare are Oswal Agro Mills, Veritas (India), S T C, Mehai Technology, Kothari Products, Sakuma Exports, Riddhi Siddhi Gl, Balgopal Commer., and Northern Spirits.<BR><BR>Quality Snapshot: Excellent management risk is observed at Oswal Agro Mills and Mehai Technology, while Average management risk is found at Sakuma Exports, Riddhi Siddhi Gl, Balgopal Commer., and Northern Spirits, and the rest have Below Average management risk. Excellent growth is seen at Oswal Agro Mills and Mehai Technology, while Average growth is noted at Sakuma Exports, and the rest have Below Average growth. Excellent capital structure is present at Oswal Agro Mills and Veritas (India), while Good capital structure is found at Sakuma Exports and Balgopal Commer., and the rest have Below Average capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Mehai Technology at 398.50%, while Veritas (India) has the lowest at -66.05%. Vikas Lifecare's 1-year return is -50.39%, which is higher than Veritas (India) but lower than Mehai Technology. Additionally, the six-month return is negative for Veritas (India), Mehai Technology, Sakuma Exports, and Vikas Lifecare.

Who are in the management team of Vikas Lifecare?

As of March 2022, the management team of Vikas Lifecare includes Arvind Gupta (CFO), Anil Kumar, Ruby Bansal, Parul Rai (Company Secretary), Vijay Kumar Sharma (CEO), Sundeep Kumar Dhawan (Managing Director), Richa Sharma, and Chandan Kumar (CFO). Each member plays a key role in the company's governance and operations.

As of March 2022, the management team of Vikas Lifecare includes the following individuals:<BR><BR>1. Arvind Gupta - Director (Finance) & CFO<BR>2. Anil Kumar - Independent Director<BR>3. Ruby Bansal - Independent Director<BR>4. Parul Rai - Company Secretary & Compliance Officer<BR>5. Vijay Kumar Sharma - Director & Chief Executive Officer<BR>6. Sundeep Kumar Dhawan - Managing Director<BR>7. Richa Sharma - Independent Director<BR>8. Chandan Kumar - Director & CFO<BR><BR>Each member holds a specific role that contributes to the governance and operational management of the company.

Is Vikas Lifecare overvalued or undervalued?

As of July 22, 2024, Vikas Lifecare is considered overvalued and risky, with a negative PE ratio of -46.72 and an EV to EBITDA of -25.23, significantly underperforming against the Sensex with a year-to-date return of -38.77%.

As of 22 July 2024, the valuation grade for Vikas Lifecare has moved from very expensive to risky, indicating a significant shift in its market perception. The company is currently considered overvalued. Key ratios reveal a PE ratio of -46.72, an EV to EBITDA of -25.23, and a Price to Book Value of 0.89, which highlight the underlying financial challenges the company faces.<BR><BR>In comparison to its peers, Vikas Lifecare's valuation metrics are concerning, particularly when contrasted with industry standards. For instance, its PE ratio is significantly negative, while the EV to EBITDA ratio also reflects a troubling trend. Notably, the company has underperformed against the Sensex, with a year-to-date return of -38.77% compared to the Sensex's positive 5.56%. This performance further reinforces the notion that Vikas Lifecare is currently overvalued in the market.

What is the technical trend for Vikas Lifecare?

As of June 4, 2025, Vikas Lifecare's technical trend is bearish, supported by daily moving averages and Bollinger Bands, despite a mildly bullish weekly MACD, indicating a prevailing bearish market sentiment.

As of 4 June 2025, the technical trend for Vikas Lifecare has changed from mildly bearish to bearish. The current stance is bearish with a moderate strength indicated by the daily moving averages and Bollinger Bands both signaling bearish trends. The weekly MACD shows a mildly bullish signal, but this is countered by the monthly MACD and KST both being bearish. The Dow Theory indicates a mildly bearish trend on the weekly timeframe, while the monthly shows no trend. Overall, the indicators suggest a prevailing bearish sentiment in the market for Vikas Lifecare.

Who are the top shareholders of the Vikas Lifecare?

The top shareholders of Vikas Lifecare include promoter Vikas Garg with 13.1%, public shareholder Sylph Technologies at 3.1%, and individual investors holding 73.79%. There are also 18 Foreign Institutional Investors with a combined 0.46% stake, and no mutual funds currently hold shares.

The top shareholders of Vikas Lifecare include Vikas Garg, who is the promoter with the highest holding at 13.1%. The highest public shareholder is Sylph Technologies, holding 3.1%. Additionally, individual investors collectively hold a significant portion of the shares at 73.79%. The company also has 18 Foreign Institutional Investors (FIIs) with a combined holding of 0.46%. Notably, there are no mutual funds currently holding shares in the company.

Has Vikas Lifecare declared dividend?

No Dividend History Available